• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS VITAMIN D TOTAL II; VITAMIN D TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS VITAMIN D TOTAL II; VITAMIN D TEST SYSTEM Back to Search Results
Catalog Number 07464215160
Device Problems High Test Results (2457); Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/26/2021
Event Type  malfunction  
Manufacturer Narrative
The qc results were acceptable.The investigation is ongoing.Unique identifier (udi) #(b)(4).
 
Event Description
There was an allegation of questionable vitamin d total g2 elecsys results for one patient sample from cobas 6000 e601 module serial number (b)(4).The initial result was >100 ng/ml with a data flag.The customer said they would typically report it as >100 ng/ml, but in this case the tech requested a rerun with decreased sample volume.The rerun result was 51.74 ng/ml.Review of the result monitor printout for the result of 51.74 ng/ml determined result does not show either a "dec" for a decreased order or "1:2" for a 1:2 dilution.It appears to have been tested with a normal sample volume.However, the customer insisted the tech requested the repeat with a decreased sample volume.The customer then performed a manual 1:2 dilution and the result was 24.64 ng/ml, which would yield a final result of 49.28 ng/ml.Per product labeling, the concentration of the diluted sample must be > or = to 40 ng/ml.The customer then repeated the sample with no dilution and the result was >100 ng/ml with a data flag.The result of 51.74 ng/ml was reported out to the physician.On (b)(6) 2021, the sample was sent to another laboratory and tested on a cobas 8000 analyzer and the result was 39.4 ng/ml.
 
Manufacturer Narrative
The calibration recovery was found to be acceptable.Based on calibration and qc data a general reagent issue could be excluded.The instrument alarm trace contained an abnormal probe sucking error.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS VITAMIN D TOTAL II
Type of Device
VITAMIN D TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11341933
MDR Text Key232324412
Report Number1823260-2021-00505
Device Sequence Number1
Product Code MRG
Combination Product (y/n)N
PMA/PMN Number
K162840
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 04/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/18/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Catalogue Number07464215160
Device Lot Number50317501
Was Device Available for Evaluation? Yes
Date Manufacturer Received01/26/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LEVATHYROXIN NA.; VENLAFAXINE HCL.; VITAMIN B12.; VITAMIN D3.; LEVATHYROXIN NA.; VENLAFAXINE HCL.; VITAMIN B12.; VITAMIN D3.
Patient Age24 YR
-
-